Fexofenadine Bluefish

What Is Fexofenadine Bluefish and What Is It Used For?

Fexofenadine Bluefish is a prescription antihistamine containing fexofenadine hydrochloride 120 mg. It is used to relieve the symptoms of seasonal allergic rhinitis (hay fever) in adults and adolescents aged 12 years and older, including sneezing, runny nose, itchy and watery eyes, and nasal congestion.

Fexofenadine belongs to the second-generation antihistamine class, which means it was developed to provide effective allergy relief without the drowsiness associated with older antihistamines like diphenhydramine and chlorphenamine. The active substance, fexofenadine hydrochloride, is the pharmacologically active metabolite of terfenadine, a first-generation antihistamine that was withdrawn from many markets due to cardiac side effects. Fexofenadine retains the therapeutic benefits of terfenadine without the cardiac risks, as it does not block cardiac potassium channels at therapeutic doses.

The 120 mg strength of Fexofenadine Bluefish is specifically indicated for the symptomatic treatment of seasonal allergic rhinitis, commonly known as hay fever. This condition affects an estimated 10–30% of the global population, according to the World Allergy Organization, making it one of the most common chronic conditions worldwide. Seasonal allergic rhinitis is triggered by airborne allergens such as tree pollen, grass pollen, and weed pollen, causing an immunoglobulin E (IgE)-mediated inflammatory response in the nasal mucosa.

The mechanism of action is straightforward: when you encounter an allergen, your immune system releases histamine from mast cells. Histamine binds to H1 receptors in the nasal passages, eyes, and skin, causing symptoms such as sneezing, itching, rhinorrhoea (runny nose), and conjunctival irritation. Fexofenadine competitively blocks these peripheral H1 receptors, preventing histamine from exerting its effects. Importantly, fexofenadine has virtually no affinity for muscarinic, alpha-adrenergic, or beta-adrenergic receptors, which contributes to its favourable side-effect profile.

Fexofenadine Bluefish is a generic medicine manufactured by Bluefish Pharmaceuticals. As a generic product, it has been approved by the European Medicines Agency (EMA) through a rigorous assessment process that confirms bioequivalence with the originator product. This means it delivers the same amount of active substance at the same rate to the systemic circulation, ensuring identical therapeutic effects. Generic medicines play a vital role in healthcare by making effective treatments more accessible and affordable.

How does fexofenadine differ from other antihistamines?

Among second-generation antihistamines, fexofenadine stands out for several reasons. It has the lowest rate of sedation in its class – multiple randomized controlled trials have demonstrated that fexofenadine causes drowsiness at rates statistically indistinguishable from placebo. This is because fexofenadine is a substrate of P-glycoprotein efflux transporters at the blood-brain barrier, which actively pump the drug back out of the central nervous system. By comparison, cetirizine, another popular second-generation antihistamine, causes measurable sedation in approximately 10% of users.

Additionally, fexofenadine does not undergo significant hepatic metabolism via cytochrome P450 enzymes, with approximately 80% of the drug excreted unchanged in faeces and urine. This gives fexofenadine a predictable pharmacokinetic profile and reduces the risk of metabolic drug interactions compared to alternatives such as loratadine, which requires hepatic activation to its active metabolite desloratadine.

What Should You Know Before Taking Fexofenadine Bluefish?

Before taking Fexofenadine Bluefish, inform your doctor if you have kidney disease, heart disease, or are pregnant or breastfeeding. Do not take this medicine if you are allergic to fexofenadine or any of the tablet's inactive ingredients.

While fexofenadine has an excellent safety profile compared to many other medications, certain precautions are essential to ensure safe and effective use. Your prescribing physician and pharmacist should be aware of your complete medical history before you start treatment. The following sections outline the key considerations.

Contraindications

Fexofenadine Bluefish should not be taken by individuals who have a known hypersensitivity (allergy) to fexofenadine hydrochloride or to any of the excipients listed in the product composition. Allergic reactions to the active substance are rare but may manifest as rash, urticaria, or in very rare cases, angioedema. If you have previously experienced an allergic reaction to terfenadine, you should inform your doctor, as cross-reactivity with fexofenadine is possible.

Warnings and Precautions

Special care should be taken in the following situations:

• Renal impairment: Patients with reduced kidney function may have higher blood levels of fexofenadine due to decreased renal excretion. If you have moderate to severe kidney disease (estimated glomerular filtration rate below 60 mL/min), your doctor may recommend a lower starting dose or increased monitoring.
• Elderly patients: Older adults are more likely to have reduced renal function and may therefore require dose adjustment. Clinical experience in elderly patients is limited compared to younger adults, though available data do not suggest an increased risk of adverse effects.
• Cardiovascular disease: While fexofenadine does not have the cardiac effects seen with terfenadine, patients with a history of significant cardiovascular disease should use caution. Clinical studies have shown no QT prolongation at therapeutic or supratherapeutic doses.
• Children under 12 years: The 120 mg strength is not recommended for children under 12 years of age. Lower-strength formulations may be available for paediatric use in some markets.

Pregnancy and Breastfeeding

The safety of fexofenadine during pregnancy has not been established through adequate and well-controlled studies in humans. Animal reproductive studies at high doses (approximately 30 times the recommended human dose) did not reveal evidence of teratogenicity or adverse effects on fertility. However, animal data do not always predict human response. Fexofenadine should only be used during pregnancy if the expected benefit to the mother outweighs any potential risk to the fetus. The European Medicines Agency classifies fexofenadine as a medicine where caution is advised during pregnancy.

Fexofenadine has been detected in breast milk in animal studies. Due to the absence of human lactation data, fexofenadine is generally not recommended during breastfeeding. If antihistamine therapy is required while breastfeeding, your doctor may suggest an alternative with more established safety data, such as cetirizine or loratadine, which have been more extensively studied in nursing mothers. Always consult your healthcare provider to weigh the benefits and risks of any medication during breastfeeding.

Effects on driving and using machines

Based on the pharmacodynamic profile and reported adverse effects, fexofenadine is unlikely to affect the ability to drive or operate machinery. Controlled clinical trials assessing psychomotor function, driving ability, and cognitive performance have consistently shown that fexofenadine 120 mg does not impair these functions compared to placebo. However, as individual responses to medications can vary, it is advisable to determine how fexofenadine affects you personally before driving or performing tasks that require full alertness.

How Does Fexofenadine Bluefish Interact with Other Drugs?

Fexofenadine has relatively few clinically significant drug interactions. The most notable interactions occur with aluminium/magnesium antacids (reduced absorption), erythromycin and ketoconazole (increased fexofenadine levels), and fruit juices (reduced bioavailability).

Drug interactions can affect how well a medication works or increase the risk of side effects. Fexofenadine has a relatively clean interaction profile compared to older antihistamines, largely because it is not significantly metabolized by cytochrome P450 enzymes. However, several interactions are still clinically relevant and should be considered.

Fexofenadine is primarily a substrate of P-glycoprotein (P-gp) and organic anion-transporting polypeptides (OATPs), particularly OATP1A2 and OATP2B1 in the intestine. Drugs and substances that inhibit or induce these transporters can alter fexofenadine plasma concentrations. Additionally, because approximately 5% of fexofenadine is metabolized by CYP3A4, potent inhibitors of this enzyme can have modest effects on drug levels.

Major Interactions

The most clinically important interaction is with aluminium and magnesium-containing antacids. These antacids form chelation complexes with fexofenadine in the gastrointestinal tract, markedly reducing its absorption. If you require antacid therapy, the standard recommendation is to separate doses by at least 2 hours – take fexofenadine first, and wait at least 2 hours before taking your antacid, or vice versa.

The interaction with fruit juices (grapefruit, orange, and apple) is also significant. These juices inhibit OATP1A2 transporters in the intestinal epithelium, which are responsible for the active uptake of fexofenadine from the gut lumen into enterocytes. Studies have demonstrated reductions in fexofenadine bioavailability of approximately 30–36% when co-administered with these juices. The practical recommendation is simple: take Fexofenadine Bluefish with a glass of water, not fruit juice.

Minor Interactions

Erythromycin and ketoconazole both increase fexofenadine plasma concentrations, primarily through inhibition of P-glycoprotein-mediated efflux in the gut. Despite the substantial increases in blood levels (82% and 135% respectively), clinical studies have not demonstrated any increase in adverse effects or QT prolongation at these elevated levels. This is because fexofenadine has a wide therapeutic index. Nevertheless, caution is advised, and patients taking these combinations should be monitored for any unusual symptoms.

Unlike many other drugs, fexofenadine does not interact significantly with alcohol. Clinical studies have shown that fexofenadine 120 mg does not potentiate the central nervous system depressant effects of alcohol, which is another advantage over older antihistamines and even some second-generation agents like cetirizine.

What Is the Correct Dosage of Fexofenadine Bluefish?

The recommended dose of Fexofenadine Bluefish for adults and adolescents aged 12 years and older is one 120 mg tablet once daily, taken with water. The tablet should be taken before a meal for optimal absorption.

Correct dosing is essential for achieving the best therapeutic results while minimizing the risk of side effects. Fexofenadine Bluefish is formulated as film-coated tablets for oral administration. The dosing regimen is straightforward, but several nuances can optimize your treatment experience.

Adults

The tablet should be taken before a meal because food can affect absorption. High-fat meals have been shown to delay the time to peak plasma concentration (Tmax) by approximately 1.5 hours and reduce the peak concentration (Cmax) by about 20%, although the total amount absorbed (AUC) is not significantly affected. For consistent and optimal results, taking the tablet on an empty stomach or just before eating is recommended.

Children

The 120 mg film-coated tablet formulation is approved for adolescents aged 12 years and older. Children aged 6–11 years may be prescribed a lower-strength formulation (typically 30 mg twice daily), which may be available as an oral suspension or smaller tablets depending on the market. Children under 6 years should not take fexofenadine unless specifically directed by a paediatric specialist, as safety and efficacy data in this age group are limited.

Elderly

No specific dose adjustment is routinely recommended for elderly patients based solely on age. However, because renal function naturally declines with age, elderly patients should have their kidney function assessed. If creatinine clearance is significantly reduced, a lower dose may be considered. Clinical experience in patients over 65 years is somewhat limited, but available data do not suggest that elderly patients are at greater risk of adverse effects than younger adults when appropriate renal adjustments are made.

Patients with Renal Impairment

Approximately 10–12% of an oral dose of fexofenadine is excreted unchanged by the kidneys. In patients with moderate to severe renal impairment, fexofenadine clearance is reduced by approximately 40–50%, leading to higher plasma levels. Regulatory guidelines suggest a starting dose of 60 mg once daily for patients with reduced renal function. Your doctor will determine the appropriate dose based on your kidney function test results.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. Missing a single dose is unlikely to cause a significant worsening of symptoms, as fexofenadine has a relatively long half-life of 11–15 hours.

Overdose

In clinical trials, doses of fexofenadine up to 800 mg (approximately 6–7 times the recommended dose) and chronic dosing up to 690 mg twice daily for one month were well tolerated without clinically significant adverse effects. The most commonly reported symptoms of overdose include dizziness, drowsiness, and dry mouth. There is no specific antidote for fexofenadine overdose. In case of suspected overdose, standard supportive measures should be employed, including monitoring of vital signs and administration of activated charcoal if the overdose is recent. Haemodialysis is not effective for removing fexofenadine from the blood due to its high degree of protein binding (60–70%).

What Are the Side Effects of Fexofenadine Bluefish?

Fexofenadine Bluefish is generally well tolerated. The most common side effects include headache, drowsiness, dizziness, and nausea. Serious side effects are rare. In clinical trials, the overall incidence of adverse effects with fexofenadine was comparable to placebo.

All medicines can cause side effects, although not everyone experiences them. Fexofenadine has one of the most favourable safety profiles among antihistamines. In large-scale clinical trials involving thousands of patients, the frequency of adverse events with fexofenadine 120 mg was remarkably similar to that observed with placebo, highlighting the excellent tolerability of this medication.

The side effects listed below are categorized by their frequency of occurrence, based on data from clinical trials and post-marketing surveillance as reported in the European Summary of Product Characteristics (SmPC) and FDA prescribing information.

It is important to note that headache, the most commonly reported adverse effect, occurred at approximately the same rate in both fexofenadine and placebo groups in controlled clinical trials (approximately 7–10% in both groups), suggesting that it may not be directly caused by the medication. Similarly, drowsiness rates with fexofenadine 120 mg (1.3–2.2%) were not statistically significantly different from placebo rates.

When to seek medical attention

While serious side effects are very rare, you should seek immediate medical attention if you experience:

• Signs of a severe allergic reaction: swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe skin rash or hives
• Rapid or irregular heartbeat, especially if accompanied by dizziness or fainting
• Chest pain or tightness
• Any other symptom that concerns you or seems unusual

Long-term safety

Fexofenadine has been available for clinical use since 1996 and has accumulated an extensive post-marketing safety record. Long-term studies of up to 12 months of continuous use have not identified any new safety concerns. There is no evidence of tachyphylaxis (tolerance) with prolonged use, meaning that fexofenadine remains effective over time without requiring dose increases. Additionally, no withdrawal effects have been observed upon discontinuation of fexofenadine, and the medication can be stopped without tapering.

How Should You Store Fexofenadine Bluefish?

Store Fexofenadine Bluefish at room temperature below 25°C in its original packaging to protect from moisture and light. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Proper storage of medications is essential to maintain their efficacy and safety throughout the shelf life. Fexofenadine Bluefish film-coated tablets should be stored under specific conditions to ensure the product remains stable and effective.

Temperature: Store at temperatures not exceeding 25°C (77°F). Do not refrigerate or freeze the tablets. Exposure to high temperatures, such as leaving the medication in a car during summer, can degrade the active substance and reduce effectiveness.

Moisture and light: Keep the tablets in their original blister packaging until ready to use. The blister pack provides protection against moisture and light, both of which can accelerate degradation. Do not transfer tablets to a pill organizer for extended periods unless it is stored in a cool, dry place.

Expiry date: Do not use Fexofenadine Bluefish after the expiry date stated on the carton and blister pack (marked “EXP”). The expiry date refers to the last day of that month. Expired medications may not only be less effective but could potentially form degradation products.

Disposal: Do not dispose of unused medications via household waste or wastewater. Return any unused tablets to your pharmacy for safe disposal. Pharmaceutical waste disposal programmes exist in most countries to prevent environmental contamination from active drug substances.

What Does Fexofenadine Bluefish Contain?

Each Fexofenadine Bluefish film-coated tablet contains 120 mg of fexofenadine hydrochloride as the active ingredient, along with several inactive excipients that form the tablet core and film coating.

Understanding the full composition of your medication can be important, particularly if you have known allergies or intolerances to specific excipients. Below is a detailed breakdown of the tablet composition.

Active ingredient

Each film-coated tablet contains 120 mg fexofenadine hydrochloride, equivalent to approximately 112 mg of fexofenadine base. Fexofenadine hydrochloride is a white to off-white crystalline powder with a molecular formula of C₃₂H₃₉NO₄·HCl and a molecular weight of 538.13 g/mol. It is freely soluble in methanol and ethanol, slightly soluble in water, and practically insoluble in hexane.

Inactive ingredients (excipients)

The inactive ingredients serve important roles in tablet manufacturing, including binding the active substance into a cohesive tablet, enabling proper dissolution in the gastrointestinal tract, and protecting the tablet with a film coat. Typical excipients in fexofenadine film-coated tablets include:

• Tablet core: Microcrystalline cellulose, pregelatinized maize starch, croscarmellose sodium (disintegrant), magnesium stearate (lubricant)
• Film coating: Hypromellose (hydroxypropyl methylcellulose), titanium dioxide (E171, white colorant), macrogol/polyethylene glycol, iron oxide yellow (E172, colorant), iron oxide red (E172, colorant)

Patients with known sensitivities should note the following: the tablet contains no lactose, gluten, or sucrose. However, individual formulations may vary slightly between manufacturers, so always check the patient information leaflet supplied with your specific product.

Frequently Asked Questions About Fexofenadine Bluefish

References and Sources

Editorial Team